[Polymorphonuclear leukocytes in dermatology. Physiology. Study methodology. Therapeutic applications].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002464:Cell Migration Inhibition; D002465:Cell Movement; D002634:Chemotaxis, Leukocyte; D003872:Dermatitis / Q000276:immunology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000276:immunology / Q000628:therapy; D007239:Infections / Q000276:immunology / Q000628:therapy; D007249:Inflammation / Q000097:blood* / Q000276:immunology; D007694:Killer Cells, Natural / Q000502:physiology; D009504:Neutrophils / Q000276:immunology / Q000502:physiology*; D009895:Opsonin Proteins / Q000502:physiology; D012871:Skin Diseases / Q000097:blood* / Q000276:immunology; D012874:Skin Diseases, Infectious / Q000276:immunology; D012882:Skin Tests
D000900:Anti-Bacterial Agents; D009895:Opsonin Proteins
Le polynucléaire en dermatologie. Physiologie. Méthodologie exploratrice. Applications thérapeutiques.